semaglutide compounding fda enforcement news The growing availability of compounded GLP-1 weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in comments⬇️ The FDA has received reports

Many M.C., Mestdagh C., Van Den Hove M.F., Denef J.F

Healing Naturally with BPC-157 Feb 4, 2022 2 min read Updated: Nov 22, 2024 In a time when were all focused on immune health, its important to note the effect illnesses can have on the wellbeing of our gut

Persistence remains mixed: a 2024 real-world study found 32% on therapy at 1 year among non-diabetic users, and according to Prime Therapeutics, only 1 in 12 remain at 3 years

In February, Novo Nordisk reported a 25 percent jump in sales from 2023 to 2024, largely thanks to Ozempic and Wegovy

More cautious dosing and closer self-monitoring make sense for older users

Black, Hispanic, American Indian and Alaska Native, and Native Hawaiian and Pacific Islander adults have higher per capita obesity rates than white adults, they are less likely to have health insurance and more likely to have lower incomes, according to a 2023 analysis from KFF